PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma von Ribas, Antoni, Algazi, Alain, Ascierto, Paolo A., Butler, Marcus O., Chandra, Sunandana, Gordon, Michael, Hernandez-Aya, Leonel, Lawrence, Donald, Lutzky, Jose, Miller, Wilson H., Campbell, Katie M., Delafont, Bruno, Marshall, Shannon, Mueller, Nancy, Robert, Caroline

Volltext

Melanoma: What do all the mutations mean? von Davis, Elizabeth J., Johnson, Douglas B., Sosman, Jeffrey A., Chandra, Sunandana

Volltext

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (... von Chae, Young Kwang, Arya, Ayush, Iams, Wade, Cruz, Marcelo R, Chandra, Sunandana, Choi, Jaehyuk, Giles, Francis

Volltext

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma von Patel, Sapna P., Othus, Megan, Chen, Yuanbin, Wright, G. Paul, Yost, Kathleen J., Hyngstrom, John R., Hu-Lieskovan, Siwen, Lao, Christopher D., Fecher, Leslie A., Truong, Thach-Giao, Eisenstein, Jennifer L., Chandra, Sunandana, Sosman, Jeffrey A., Kendra, Kari L., Wu, Richard C., Devoe, Craig E., Deutsch, Gary B., Hegde, Aparna, Khalil, Maya, Mangla, Ankit, Reese, Amy M., Ross, Merrick I., Poklepovic, Andrew S., Phan, Giao Q., Onitilo, Adedayo A., Yasar, Demet G., Powers, Benjamin C., Doolittle, Gary C., In, Gino K., Kokot, Niels, Gibney, Geoffrey T., Atkins, Michael B., Shaheen, Montaser, Warneke, James A., Ikeguchi, Alexandra, Najera, Jose E., Chmielowski, Bartosz, Crompton, Joseph G., Floyd, Justin D., Hsueh, Eddy, Margolin, Kim A., Chow, Warren A., Grossmann, Kenneth F., Dietrich, Eliana, Prieto, Victor G., Lowe, Michael C., Buchbinder, Elizabeth I., Kirkwood, John M., Korde, Larissa, Moon, James, Sharon, Elad, Sondak, Vernon K., Ribas, Antoni

Volltext

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies von St-Pierre, Frederique, Bhatia, Shailender, Chandra, Sunandana

Volltext

Repurposing metformin for cancer treatment: current clinical studies von Chae, Young Kwang, Arya, Ayush, Malecek, Mary-Kate, Shin, Daniel Sanghoon, Carneiro, Benedito, Chandra, Sunandana, Kaplan, Jason, Kalyan, Aparna, Altman, Jessica K, Platanias, Leonidas, Giles, Francis

Volltext

Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer von Walz, Amy, Ugolkov, Andrey, Chandra, Sunandana, Kozikowski, Alan, Carneiro, Benedito A, O'Halloran, Thomas V, Giles, Francis J, Billadeau, Daniel D, Mazar, Andrew P

Volltext

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis von Johnson, Douglas B., McDonnell, Wyatt J., Gonzalez-Ericsson, Paula I., Al-Rohil, Rami N., Mobley, Bret C., Salem, Joe-Elie, Wang, Daniel Y., Sanchez, Violeta, Wang, Yu, Chastain, Cody A., Barker, Kristi, Liang, Yan, Warren, Sarah, Beechem, Joseph M., Menzies, Alexander M., Tio, Martin, Long, Georgina V., Cohen, Justine V., Guidon, Amanda C., O’Hare, Méabh, Chandra, Sunandana, Chowdhary, Akansha, Lebrun-Vignes, Bénédicte, Goldinger, Simone M., Rushing, Elisabeth J., Buchbinder, Elizabeth I., Mallal, Simon A., Shi, Chanjuan, Xu, Yaomin, Moslehi, Javid J., Sanders, Melinda E., Sosman, Jeffrey A., Balko, Justin M.

Volltext

Targeted Therapy for Melanomas Without BRAF V600 Mutation von Choi, Jacob S., Chandra, Sunandana

Volltext

Endocrine side effects of immune checkpoint inhibitors von Cardona, Zulma, Sosman, Jeffrey A, Chandra, Sunandana, Huang, Wenyu

Volltext

Immune Checkpoint Inhibitor Toxicity in 2018 von Johnson, Douglas B, Chandra, Sunandana, Sosman, Jeffrey A

Volltext

Nodal Signaling as a Developmental Therapeutics Target in Oncology von Kalyan, Aparna, Carneiro, Benedito A, Chandra, Sunandana, Kaplan, Jason, Chae, Young Kwang, Matsangou, Maria, Hendrix, Mary J C, Giles, Francis

Volltext

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma von Mehnert, Janice M, Mitchell, Tara C, Huang, Alexander C, Aleman, Tomas S, Kim, Benjamin J, Schuchter, Lynn M, Linette, Gerald P, Karakousis, Giorgos C, Mitnick, Sheryl, Giles, Lydia, Carberry, Mary, Frey, Noelle, Kossenkov, Andrew, Groisberg, Roman, Hernandez-Aya, Leonel F, Ansstas, George, Silk, Ann W, Chandra, Sunandana, Sosman, Jeffrey A, Gimotty, Phyllis A, Mick, Rosemarie, Amaravadi, Ravi K

Volltext

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma von Ribas, Antoni, Algazi, Alain, Ascierto, Paolo A., Butler, Marcus O., Chandra, Sunandana, Gordon, Michael, Hernandez-Aya, Leonel, Lawrence, Donald, Lutzky, Jose, Miller, Wilson H., Campbell, Katie M., Delafont, Bruno, Marshall, Shannon, Mueller, Nancy, Robert, Caroline

Volltext

Pseudoprogression of Melanoma Brain Metastases von Simard, Jillian L., Smith, Melanie, Chandra, Sunandana

Volltext

Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy von Chandra, Sunandana, Zheng, Ying, Pandya, Shivani, Yu, Ting, Kearney, Mairead, Wang, Li, Kim, Ruth, Phatak, Hemant

Volltext

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA von Chae, Young Kwang, Davis, Andrew A, Carneiro, Benedito A, Chandra, Sunandana, Mohindra, Nisha, Kalyan, Aparna, Kaplan, Jason, Matsangou, Maria, Pai, Sachin, Costa, Ricardo, Jovanovic, Borko, Cristofanilli, Massimo, Platanias, Leonidas C, Giles, Francis J

Volltext

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling von Chae, Young Kwang, Chung, Su Yun, Davis, Andrew A, Carneiro, Benedito A, Chandra, Sunandana, Kaplan, Jason, Kalyan, Aparna, Giles, Francis J

Volltext

Leptomeningeal metastases: the future is now von Lukas, Rimas V., Thakkar, Jigisha P., Cristofanilli, Massimo, Chandra, Sunandana, Sosman, Jeffrey A., Patel, Jyoti D., Kumthekar, Priya, Stupp, Roger, Lesniak, Maciej S.

Volltext

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study von Najjar, Yana G, Navrazhina, Kristina, Ding, Fei, Bhatia, Roma, Tsai, Katy, Abbate, Kelly, Durden, Barbara, Eroglu, Zeynep, Bhatia, Shailender, Park, Song, Chowdhary, Akansha, Chandra, Sunandana, Kennedy, Jonathan, Puzanov, Igor, Ernstoff, Marc, Vachhani, Pankit, Drabick, Joseph, Singh, Arun, Xu, Tan, Yang, Jessica, Carvajal, Richard, Manson, Daniel, M Kirkwood, John, Cohen, Justine, Sullivan, Ryan, Johnson, Douglas, Funchain, Pauline, Shoushtari, Alexander

Volltext